DISC1: A Schizophrenia Gene with Multiple Personalities  by Wexler, Eric M. & Geschwind, Daniel H.
Neuron
Previewsand structural/functional imaging data
sets obtained from a genetically informa-
tive sample of 1,200 subjects composed
of kindred sets of twins (monozygotic
and dizygotic) and their nontwin siblings.
Data from the HCP, freely available to
the public, will allow investigators to relate
genetic factors not only to cortical surface
regionalization but also to brain structure,
connectivity, function, and behavior. The
potential utility of these data sets,
together with the findings from Chen
et al. (2011), marks an exciting new
chapter for the study of human brain
development.
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Two papers address the contribution of DISC1 to neural development and schizophrenia risk in this issue
of Neuron. These complementary studies elegantly bridge the gap between genetic and cellular studies
of schizophrenia, providing a level of functional validation that is often lacking in the field.Schizophrenia is a cognitive disorder af-
flictingmore than 1%of adults worldwide.
Beginning in early adulthood, patients
with schizophrenia develop symptoms
that include auditory hallucinations, delu-
sions, loss of linear and logical thinking,
disorganized language, and often a blunt-
ing of emotion, motivation, and socializa-
tion, which is similar to the presentation
of autism. The risk of developing schizo-
phrenia is primarily attributable to genetic
rather than environmental factors, with
a heritability that is thought to exceed
75%. In theory, this high degree of herita-bility should facilitate the discovery of
the primary causes of schizophrenia; in
practice, validation of candidate schizo-
phrenia genes has proved elusive.
Schizophrenia literally means ‘‘split
mind.’’ This is an aptmetaphor to describe
the divide that has evolved between the
schizophrenia genetics and cell biology
literature and that is partially attributable
to the disparate methods that each
discipline employs. For example, genetic
association studies find candidate genes
by linking disease occurrence to the
presence of specific single nucleotidepolymorphisms (SNPs), many of which
are nonfunctional. Interpreting the phys-
ical significance of these results can be
perplexing to experimentalists, who are
not accustomed to relying on abstract
statistical methods. Because it is difficult
to bridge this gap, few studies are able
to provide a mechanism that plausibly
explains how aberrant functioning of the
identified gene could lead to the onset of
schizophrenia. These pitfall was cleverly
surmounted by two innovative studies in
this issue of Neuron focusing on the
biology of the schizophrenia candidateovember 17, 2011 ª2011 Elsevier Inc. 501
Neuron
PreviewsgeneDISC1 (Kanget al., 2011; Singh et al.,
2011).
In 1968, a cytogenetic survey of Scot-
tish juvenile delinquents detected a single
boy who carried a balanced translocation
from chromosome 11 into the long arm of
chromosome 1. Later analysis revealed
a major mental illness in roughly half
of those family members carrying the
t(1;11) translocation, whereas only 1 in
10 cytogenetically normal relatives were
so afflicted (St Clair et al., 1990). Three
decades after its initial discovery, it was
recognized that this insertion truncates
the gene now known as disrupted in
schizophrenia 1 (DISC1), a bit of mis-
nomer given that schizophrenia was less
prevalent than major mood disorders
in the t(1:11) proband (Millar et al.,
2000). This association with schizo-
phrenia was first corroborated through
linkages studies of the Finnish population
and later by using SNP-haplotype
(genome-wide) association studies of
Caucasian and Asian cohorts.
DISC1 is a large scaffolding protein
(93 kDa) that is widely expressed
throughout the fetal and adult brain, most
prominently in the human hippocampus.
Initially, yeast two-hybrid screens indenti-
fied a host of DISC1 binding partners,
including MAP1a, GSK-3b, and PDE4,
which bind the N-terminal domain; FEZ1,
which binds in the region containing the
original t(1,11) disruption; and NDEL1
and LIS1, which bind near the C terminus.
Moreover, association studies have
linked PDE4, FEZ1, and NDEL1 with
disease onset, though none have been
rigorously validated (reviewed by Chubb
et al., 2008). Given the wide variety of
binding partners, it is not surprising that
DISC1 mediates a plethora of different
biological functions, both in vitro and
in vivo. Some examples include regulating
neuroblast migration (Duan et al., 2007;
Ishizuka et al., 2011) or the proliferation
of neural progenitors via an interaction
with GSK-3b (Mao et al., 2009; Singh
et al., 2010).
Signaling through GSK-3b is a key
step in the canonical Wnt pathway.
This family of pathways is essential for
proper development of the fetal fore-
brain-hippocampus and midbrain dopa-
minergic systems, the brain regions
most frequently implicated in the etiology
of schizophrenia and bipolar affective502 Neuron 72, November 17, 2011 ª2011 Edisorder. In fact, one of the first trans-
genic animal models of schizophrenia
was the result of knocking out the Wnt
transducing protein disheveled (Lijam
et al., 1997). GSK-3b and Wnt signaling
also play critical roles in the development
and function of neuronal circuits in the
adult brain. Over the past decade,
numerous studies have appeared in
the literature reporting aberrations in
Wnt signaling in the brains of schizo-
phrenic patients. However, most of these
results have proved difficult to repro-
duce, with the notable exception of
DISC1 modulation of GSK-3b (reviewed
in Hur and Zhou, 2010; Inestrosa and
Arenas, 2010).
The present study by Tsai and
colleagues (Singh et al., 2011) posed the
following questions: Do genetic changes
in DISC1 that have been linked to schizo-
phrenia alter canonical Wnt signaling?
And if so, how do they affect neuronal
development? They addressed these
questions by using a highly innovative
combination of in vivo and in vitro model
systems that span three species (mouse,
zebrafish, and human). Their novel exper-
imental approach began by resequencing
the exomes of over 700 schizophrenic,
bipolar, or control patients. This allowed
them to derive a set of common and rare
DISC1 variants to explore further. Then
they focused on validating the function-
ality of individual nonsynonymous (i.e.,
protein-altering) SNPs. Each of these
SNPs causes single amino acid changes
to DISC1 and include the common
missense variants R264Q, L607F, and
S704C, as well as the rare variant A83V
(reviewed in Chubb et al., 2008).
By using a standard assay of canonical
Wnt signaling, they demonstrated that
wild-type DISC1 potentiates canonical
Wnt signaling in human and mouse cell
lines. However, this potentiation was
abrogated by amino acid substitutions
near the GSK-3b binding site, but not by
a more distal substitution. In sum, these
SNPs reduced canonical Wnt signaling
by altering DISC1’s interaction with
GSK-3b. When tested in mice, the SNPs
that reduce canonical activity produced
a commensurate decrease in neural pro-
genitor cell proliferation and an increase
in neuronal fate commitment. This is
consistent with studies demonstrating
that human neural progenitors requirelsevier Inc.baseline canonical Wnt activity to remain
proliferative and undifferentiated (Wexler
et al., 2009).
Another innovative aspect of this study
was the authors’ ability to validate their
findings using human lymphoblast cells
lines, derived from patients harboring
each of the common SNPs. Specifically,
they showed that Wnt stimulation pro-
duced less activation of the canonical
pathways in lymphoblasts homozygous
for the 264QQ polymorphisms, compared
to those wild-type cells (i.e., RR264). They
also found that Wnt-stimulated signaling
was significantly lower in lymphoblasts
from bipolar patients, compared to con-
trols. This further supports the hypothesis
that lithium’s efficacy in treating bipolar
disorder stems from its ability to restore
adequate Wnt signaling in affected indi-
viduals, given that lithium mimics canon-
ical signaling, including in neural adult
progenitors (Wexler et al., 2008). Although
these data are intriguing, they must be
interpreted cautiously, because lympho-
blasts can only partially recapitulate the
behavior of neurons. Ideally, these find-
ings will be further validated in patient-
derived human neurons produced by
cellular reprogramming (Brennand et al.,
2011).
The Song and Ming laboratories took
a complementary approach to integrating
genetic and functional data (Kang et al.,
2011). They examined the postnatal roles
of DISC1 interacting with fasciculation
and elongation protein zeta-1 (FEZ1) and
nudeE-like 1 (NDEL1), both of which
regulate neural migration in utero. An
important feature of this study was that
they investigated the function of DISC1
in the adult brain, because there is a
bias toward exclusively studying candi-
date schizophrenia genes in the context
of early brain development. Early brain
development probably plays a significant,
but poorly understood, role in the onset of
schizophrenia later in life (Niwa et al.,
2010; Thompson and Levitt, 2010). Yet
schizophrenia is still a disorder of early
adulthood, with clinically defining symp-
toms rarely occurring before midadoles-
cence or after midlife. Therefore, it is
important to understand how candidate
genes function in the adult brain, and
their analysis of newborn neurons in the
adult hippocampus offers an interesting
model to begin to address genetic
Neuron
Previewscontributions to both aspects of develop-
ment and adult function.
They found that loss of FEZ1 increased
neuronal soma size and increased length
of dendrites in newborn neurons in the
adult dentate gyrus, reminiscent of the
effects of knocking down DISC1. More-
over, the combined loss of both genes
synergistically increased dendritic length.
In contrast, loss of NDEL1 increased
the appearance of ectopic dendrites and
led to aberrant somatic positioning.
Again, in contrast to FEZ1, knocking
down both DISC1 and NDEL1 produced
a phenotype similar to NDEL knockdown
alone. Specifically, these experiments
suggest that DISC1 primarily regulates
neuronal migration and dendritic sprout-
ing through an NDEL-dependent process.
However, the regulation of dendrite and
soma growth occurs through FEZ1-
dependent and -independent pathways.
This work demonstrates that DISC1 regu-
latesmultiple developmental processes in
parallel and that these individual pro-
cesses can be teased apart when using
the appropriate model systems.
Given such strong experimental
evidence that the interaction between
FEZ1-DISC1 regulates neuronal develop-
ment, it is surprising that FEZ1 shows
such a poorly reproducible association
with schizophrenia. This could be the
result of a truly weak association, or it
could be because prior studies were
underpowered, two sides of the same
coin. However, the authors’ critical insight
was realizing that the relevant association
is not between schizophrenia and FEZ1
polymorphisms, but rather with the
FEZ1-DISC1 functional unit. In genetic
terms, they hypothesized an epistatic
interaction between DISC1 and FEZ1
that segregates with disease. They testedfor such an interaction by first selecting
four FEZ1 haplotype-tagging SNPs to
reduce multiple comparisons. None
were associated with a significant risk
for schizophrenia, by themselves.
However, a significant association was
uncovered when they conditioned their
analysis on the presence of the common
DISC1-S704C polymorphism. Using a
much larger patient cohort, they
confirmed that their best FEZ1 SNP
conditioned on the DISC1-S704C poly-
morphism remained significantly associ-
ated with disease, though the correlation
was inverted. This discrepancy can arise
for a host of reasons. Because in this
case these four tagging SNPs are not
functional variants, it may be that the
true functional variants occur on different
haplotypes in different populations, or
this may represent a spurious result.
These data, however, are strong and
warrant further attempts at replication.
Moreover, they suggest the worth of
studying epistasis from a pathway
perspective. Taken together, these works
by Tsai, Ming, and colleagues demon-
strate successful strategies for inte-
grating genetic and cell biological studies
of schizophrenia, which we expect will
become the norm in this field.REFERENCES
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